Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Surgery|February 23, 2008
Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breastSatsuki Ueda, Yasuhiro Tamaki, Kenji Yano, et al.
Human Pathology|July 27, 2021
α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiationHarumi Nakamura, Yoji Kukita, Kei Kunimasa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 4, 2012
Presynaptic dystroglycan-pikachurin complex regulates the proper synaptic connection between retinal photoreceptor and bipolar cellsYoshihiro Omori, Fumiyuki Araki, Taro Chaya, et al.
Gastrointestinal Endoscopy|October 25, 2002
Molecular analysis of diminutive, flat, depressed colorectal lesions: are they precursors of polypoid adenoma or early stage carcinoma?Tetsushi Morita, Naohiro Tomita, Masayuki Ohue, et al.
Molecular and Clinical Oncology|March 21, 2014
Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastasesYoshiko Okita, Yoshitaka Narita, Tsuyoshi Suzuki, et al.
Cancer|January 19, 2012
Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in JapanYasuhiro Tamaki, Nobuaki Sato, Keiichi Homma, et al.
Journal of Cancer Research and Clinical Oncology|October 17, 2007
Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancersYasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, et al.
Cancer Letters|February 19, 2008
Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancersYasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, et al.
The Breast Journal|November 13, 2008
Potential of reduction in total tumor volume measured with 3D-MRI as a prognostic factor for locally-advanced breast cancer patients treated with primary chemotherapyKenji Akazawa, Yasuhiro Tamaki, Tetsuya Taguchi, et al.
Breast Cancer (Tokyo, Japan)|October 2, 2023
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancerHiroki Kusama, Nobuyoshi Kittaka, Ai Soma, et al.
Pageof 19